Review: A Japanese population-based meta-analysis of vonoprazan versus PPI forHelicobacter pylorieradication therapy: Is superiority an illusion?
Author:
Affiliation:
1. Department of Gastroenterology; Zhongnan Hospital of Wuhan University; Wuhan China
Publisher
Wiley
Subject
Infectious Diseases,Gastroenterology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hel.12438/fullpdf
Reference35 articles.
1. Population screening and treatment of Helicobacter pylori infection;O'Connor;Nat Rev Gastroenterol Hepatol,2017
2. Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report;Malfertheiner;Gut,2017
3. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits;Graham;Gastroenterology,2015
4. Helicobacter pylori: perspectives and time trends;Malfertheiner;Nat Rev Gastroenterol Hepatol,2014
5. Screening and treating Helicobacter pylori infection for gastric cancer prevention on the population level;Lee;J Gastroenterol Hepatol,2017
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments;Current Gastroenterology Reports;2024-08-15
2. Efficacy and Safety of Vonoprazan-Based Quadruple Therapy for the Eradication of <i>Helicobacter pylori</i> in Patients with Peptic Ulcers: A Pooled Analysis of Two Randomized, Double-Blind, Double-Dummy, Phase 3 Trials;Biological and Pharmaceutical Bulletin;2024-08-01
3. Single-Arm, Prospective, Interventional Study of Helicobacter pylori Eradication Rescue Therapy with Rifabutin, Metronidazole, and Vonoprazan;Journal of Clinical Medicine;2024-06-27
4. Comparison of metronidazole versus clarithromycin in first‐line vonoprazan‐based triple therapy for Helicobacter pylori: A multicenter randomized trial in Japan;JGH Open;2024-04
5. Vonoprazan a novel potassium competitive acid blocker; another leap forward;Gastroenterology Review;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3